A trial of Insmed’s TPIP suggests daily doses of the inhaled dry powder are well tolerated and may improve blood flow in ...

A study involving more than 270,000 women found that women who work overnight were more likely to suffer from asthma.

One person was taken to the hospital for smoke inhalation treatment after a fire in Johnson City on Saturday. The Johnson ...

The GINA 2025 asthma update includes new guidance on T2 biomarkers, asthma in young children, and climate change.

Insmed Incorporated (NASDAQ:INSM) is a New Jersey-based biopharmaceutical company that develops and markets therapies to ...

PVSC officials say another Sandy-like outage would spell catastrophe. Critics decry added pollution, environmental racism.

Asthma incidence in adults is positively associated with lipid accumulation product (LAP) levels, according to study findings published in Respiratory Medicine.

Some asthma therapy appeared to be less effective in Black children living in areas with high levels of nitrogen dioxide (NO2).

Treprostinil palmitil inhalation powder (TPIP) for pulmonary arterial hypertension (PAH) showed promising results in a ...

Guggenheim Partners called Insmed’s Phase IIb readout “impressive across the board,” with an efficacy profile that positions ...

Insmed achieved positive phase 2b results for TPIP in PAH. Click here to find out why INSM stock is a Strong Buy.

In the DD group 41% of patients were considered treatment failures because they either required systemic steroids (n = 12), had an unscheduled visit to a physician (n = 1), or their asthma did not ...